Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

With pharmaceutical and biotechnology R&D witnessing unprecedented growth, molecular spectroscopy methods such as nuclear magnetic resonance (NMR), Fourier transform infrared (FTIR), and Raman ...

Innovative glass functionalization via ultrasonication creates stable Si–O–C bonds, addressing traditional method limitations ...

Synthetic cannabinoids, a class of new psychoactive substances, bind to cannabinoid receptors CB1 and CB2 much more strongly than tetrahydrocannabinol (THC) and cannabidiol (CBD), raising public ...

Results were announced from a phase 3 trial evaluating cebranopadol for the treatment of moderate to severe acute pain in patients following bunionectomy surgery.

DSECF Daiwa Securities Group Inc.

California-based Latigo Biotherapeutics, a biotech developing non-opioid pain treatments, has closed $150 million in a Series B financing.

Polyphosphate (polyP) exists in all life forms; however, its biological functions in metazoans are understudied. Here, we explored Drosophila as the first genetic model to explore polyP biology in ...

Gold is back at an ALL TIME HIGH, nudging US$2990/oz which, for those playing at home, puts us well within reach of the ...

Back in 1934, Ralph Nelson Elliott discovered that price action displayed on charts, instead of behaving in a somewhat chaotic manner, had actually an intrinsic narrative attached. Elliot saw the ...